Pancytopenia and marrow infiltration: Case

Framing the case

This four-year-old boy has the classic presentation of acute leukaemia with marrow infiltration. The trilineage cytopenia, the circulating blasts, the organomegaly and the lymphadenopathy, alongside the three-week history of pallor, bruising and fever, together make a marrow malignancy the working diagnosis, and the first decision is to move the child from an elective workup to an emergency resuscitation. The framework that organises the case is the empty-versus-full marrow distinction, and here the blasts and the organomegaly settle the marrow as full. [1][3]

Immediate assessment and stabilisation

The assessment begins with the airway, breathing and circulation, because a child with a severe anaemia, a bleeding risk and a fever is in danger before any diagnosis is reached. The child is admitted to a paediatric haematology-oncology centre, and the resuscitation rests on three legs. Red cells are transfused for the symptomatic anaemia, given slowly to avoid circulatory overload, with all cellular products irradiated and leucodepleted to prevent transfusion-associated graft-versus-host disease. Platelets are transfused for the count under twenty times ten to the nine per litre in this febrile child. [12]

Tumour lysis prophylaxis begins before the first chemotherapy dose, with hyperhydration using an isotonic fluid without potassium, rasburicase for the high-risk child, and four-to-six-hourly biochemistry of the potassium, phosphate, calcium, creatinine and urate. The glucose-6-phosphate dehydrogenase status is checked before the rasburicase because it is contraindicated in the deficiency. Blood cultures are drawn and an empiric antipseudomonal beta-lactam such as piperacillin-tazobactam is given within one hour for the febrile neutropenia, with a neutrophil count under 0.5 times ten to the nine per litre. [12]

The diagnostic pathway

The bone marrow aspirate and trephine biopsy are performed together at the posterior iliac crest once the child is stable. The aspirate provides the cells for morphology, for flow cytometry to define the lymphoid lineage and the immunophenotype, and for the molecular studies. The trephine biopsy provides the architecture and the cellularity. The cytogenetics and the molecular panel, including the ETV6-RUNX1 and the KMT2A rearrangements and the copy-number changes, drive the risk stratification. The peripheral film is read personally with the haematologist, because the blasts, the leucoerythroblastic picture, or the teardrop poikilocytes change the working diagnosis in seconds. [3][11]

The named diagnosis and the definitive management

The bone marrow confirms B-cell precursor acute lymphoblastic leukaemia, standard risk by age and the initial white cell count, with a favourable cytogenetic finding of the ETV6-RUNX1 fusion. The definitive management is risk-stratified multi-agent chemotherapy delivered over two and a half years through the phases of remission induction, consolidation, delayed intensification, and maintenance, with central nervous system-directed therapy and the monitoring of the minimal residual disease at the end of induction as the key determinant of the intensity that follows. The contemporary survival of standard-risk childhood acute lymphoblastic leukaemia exceeds ninety percent on the best modern protocols. [3]

The boy is enrolled on the national protocol, and the multidisciplinary team is assembled: the paediatric oncologist, the clinical nurse specialist, the pharmacist, the social worker, the psychologist, and the educational liaison. The family is taught the neutropenic precautions, the fever as an emergency, the central line care, and the recognition of the late effects. The survivorship plan is begun from the day of diagnosis, with the surveillance for the anthracycline cardiotoxicity, the endocrine late effects, and the second malignancy risk. [3]

Contrasting the empty marrow

The examiner asks the candidate to contrast this full-marrow leukaemia with the empty-marrow aplastic anaemia and the transient marrow failure of parvovirus B19. A child with severe acquired aplastic anaemia would have the same trilineage cytopenia but a hypocellular marrow with fat replacement, no organomegaly, and no clone, and would be defined by the Camitta criteria and treated by a matched sibling transplant or by the antithymocyte globulin and ciclosporin immunosuppression. A child with parvovirus B19 pure red cell aplasia would have a sudden fall in haemoglobin with a near-zero reticulocyte count, often in the setting of a chronic haemolysis, and would be treated supportively or with intravenous immunoglobulin. Holding these three mechanisms together is the framework that organises the whole topic. [9][10]

Communication and the family

The family is counselled honestly and hopefully. The candidate names the diagnosis, explains that it is the commonest childhood cancer, that the contemporary survival exceeds ninety percent on the modern protocols, and that the treatment runs over two to three years. The parents are introduced to the multidisciplinary team, given a written plan, taught the fever and the bleeding emergencies, and supported by the social work and the educational liaison. The child is prepared in an age-appropriate way, and the siblings and the school are included. The fellow who can hold the science and the humanity together in this conversation, and who can return to the empty-versus-full marrow distinction at any point the examiner probes, demonstrates the reasoning the boards reward. [3]